Browse Guides  internal medicine  cardiology

Atrial fibrillation

Prevalence
Causes
Clinical features
Investigations
Therapy
Prevention
Prognosis
Therapy

Acute-onset atrial fibrillation

Control the ventricular rate using d digoxin  a  

Alternatives include
  • calcium channel blockers: verapamil a or diltiazem a
  • beta blockers: esmolol a  or sotalol a  
  • clonidine b  
Consider cardioversion to sinus rhythm a if your patient fails to revert spontaneously d or is haemodynamically compromised.

Options include

  • DC cardioversion a
    Cardioversion is more likely to be successful if  a  
    • the onset of this episode of arrythmia is recent 
    • your patient is young 
    Anticoagulate your patient before and after cardioversion c  

    Consider 

    • using transoesophageal echocardiography to determine when to perform the cardioversion  a
    • giving an initial shock of 360 J if AF duration > 48 hours a
    • internal cardioversion a  
    • giving an infusion of ibutilide before cardioversion a  

    There is no clear benefit from
    • using propafenone before DC cardioversion d  
    • different pad d or electrode positions d  

     

  • pharmacological cardioversion
    • flecainide iv or oral   a  
    • ibutilide a  
    • procainamide a  
    • propafenone a  
    • amiodarone iv or oral a  
    • quinidine and verapamil a

 

Chronic atrial fibrillation

Control the ventricular rate a using any of
  • calcium-channel blockers a: verapamil a or diltiazem  a
  • beta-blockers a: esmolol a  or sotalol a
  • digoxin a preferably in combination with a calcium-channel blocker or beta-blocker
  • clonidine b  
Consider conversion to sinus rhythm a using DC cardioversion c followed by amiodarone b
  • See acute AF section for more details.
Cardioversion is less likely to be successful in the long term if patients 
  • have had AF for more than 3 months a  
  • have severe heart failure a  
  • are old a  
and more likely if they have non-rheumatic mitral valve disease  a  


Alternatives to amiodarone include 

  • flecainide b  
  • disopyramide a  

    There is no clear benefit from adding a

    • propafenone
    • quinidine
    • sotalol

     

Consider pharmacological cardioversion if your patient is unsuitable for DC cardioversion, d using one of 
  • ibutilide or oral dofetilide a  
  • flecainide a
  • amiodarone a  
  • propafenone a  
  • quinidine a
There is no clear benefit from a
  • disopyramide
  • magnesium
  • digoxin
  • sotalol d

For patients with symptomatic chronic AF resistant to medication, consider

  • radiofrequency AV node modulation c  
  • atriotomy c  

Expiry date: February 2003
Levels of Evidence used in grading these guides

Authors   CM   Ball , N   Shenker
Reviewer   R G   Hart
CAT Writers   CM   Ball , N   Shenker , CJ   Wotton